Skip to main content

Table 4 Status of tracer indicator scores for all cancer tracer indicators at each level of health facility (n = 323)

From: Assessing service availability and readiness to manage cervical cancer in Bangladesh

Tracer Items Total Tertiary & Specialized Hospital District Hospital MCWC UHC NGO/Private Hospital
Staff and guideline [n (index score in %)]
 Oncologists 31 (9.6) 7 (100.0) 9 (15.5) 0 (0.0) 1 (0.8) 14 (18.9)
 Palliative care specialist 4 (1.2) 3 (42.9) 1 (1.7) 0 (0.0) 0 (0.0) 0 (0.0)
 Trained Nurse 9 (2.8) 5 (71.4) 2 (3.4) 0 (0.0) 1 (0.8) 1 (1.4)
 Guideline a 41 (12.7) 7 (100.0) 10 (17.2) 3 (5.0) 11 (8.9) 10 (13.5)
 Training a 32 (9.9) 7 (100.0) 6 (10.3) 3 (5.0) 13 (10.5) 3 (4.1)
Equipment [n (index score in %)]
 Beds available for cancer patients 26 (8.0) 7 (100.0) 7 (12.1) 0 (0.0) 8 (6.5) 4 (5.4)
 Speculum a 152 (47.1) 7 (100.0) 36 (62.1) 28 (46.7) 57 (46.0) 24 (32.4)
Diagnostic facility [n (index score in %)]
 Acetic Acid a 136 (42.1) 6 (85.7) 36 (62.1) 27 (45.0) 53 (42.7) 14 (18.9)
 Sputum for Cytology 80 (24.8) 7 (100.0) 20 (34.5) 1 (1.7) 27 (21.8) 25 (33.8)
 Stool occult blood test (OBT) 75 (23.2) 7 (100.0) 14 (24.1) 1 (1.7) 21 (16.9) 32 (43.2)
 Cancer antigen 15.3 (CA 15.3) 24 (7.4) 5 (71.4) 3 (5.2) 1 (1.7) 1 (0.8) 14 (18.9)
 Cancer antigen 19.9 (CA 19.9) 23 (7.1) 5 (71.4) 3 (5.2) 1 (1.7) 1 (0.8) 13 (17.6)
 Carcinoembryonic antigen (CEA) 23 (7.1) 5 (71.4) 3 (5.2) 1 (1.7) 1 (0.8) 13 (17.6)
 Cancer antigen 125 (CA125) 23 (7.1) 5 (71.4) 3 (5.2) 1 (1.7) 1 (0.8) 13 (17.6)
 Alpha Keto Protein 25 (7.7) 5 (71.4) 3 (5.2) 1 (1.7) 2 (1.6) 14 (18.9)
 Endoscopy of upper gastrointestinal tract 43 (13.3) 7 (100.0) 10 (17.2) 0 (0.0) 4 (3.2) 22 (29.7)
 Colonoscopy 35 (10.8) 7 (100.0) 8 (13.8) 0 (0.0) 2 (1.6) 18 (24.3)
 Pituitary tumor-transforming gene 1-binding factor (PBF) 55 (17.0) 7 (100.0) 14 (24.1) 0 (0.0) 7 (5.6) 27 (36.5)
 Bone Marrow Study 21 (6.5) 7 (100.0) 2 (3.4) 0 (0.0) 1 (0.8) 11 (14.9)
 Biopsy for Histopathology 35 (10.8) 7 (100.0) 9 (15.5) 0 (0.0) 1 (0.8) 18 (24.3)
 Fine Needle Aspiration Cytology (FNAC) 35 (10.8) 6 (85.7) 8 (13.8) 0 (0.0) 1 (0.8) 20 (27.0)
Medicines [n (index score in %)]
 Hydrocortisone 150 (46.4) 7 (100.0) 33 (56.9) 18 (30.0) 57 (46.0) 35 (47.3)
 Pheniramine 61 (18.9) 5 (71.4) 11 (19.0) 10 (16.7) 17 (13.7) 18 (24.3)
 Ondanseron 84 (26.0) 6 (85.7) 20 (34.5) 6 (10.0) 22 (17.7) 30 (40.5)
 Haloperidol 40 (12.4) 6 (85.7) 11 (19.0) 3 (5.0) 4 (3.2) 16 (21.6)
 Morphin injection 28 (8.7) 6 (85.7) 8 (13.8) 2 (3.3) 4 (3.2) 8 (10.8)
 Morphin tablet 23 (7.1) 4 (57.1) 7 (12.1) 1 (1.7) 4 (3.2) 7 (9.5)
 Lorazepam 47 (14.6) 5 (71.4) 12 (20.7) 4 (6.7) 10 (8.1) 16 (21.6)
 Hyoscine butylebromide 65 (20.1) 7 (100.0) 13 (22.4) 6 (10.0) 21 (16.9) 18 (24.3)
 Broad Spectrum Antibiotics 151 (46.7) 7 (100.0) 37 (63.8) 20 (33.3) 55 (44.4) 32 (43.2)
 Chemotherapeutic drugs 17 (5.3) 5 (71.4) 2 (3.4) 1 (1.7) 3 (2.4) 6 (8.1)
  1. aindicators that are specific for determining service readiness for cervical cancer patients